Cargando…
ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma
Over the last few years, a significant progress has been made in understanding the role of a disintegrin and metalloproteinase 33 (ADAM33) in asthma. The previous observations for the association with asthma have been replicated in over 33 different population samples worldwide. We and others have p...
Autores principales: | Tripathi, Priya, Awasthi, Shally, Gao, Peisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003756/ https://www.ncbi.nlm.nih.gov/pubmed/24817794 http://dx.doi.org/10.1155/2014/572025 |
Ejemplares similares
-
Role of ADAM33 gene and associated single nucleotide polymorphisms in asthma
por: Sharma, Neeraj, et al.
Publicado: (2011) -
Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls
por: Tripathi, Priya, et al.
Publicado: (2013) -
Association between ADAM metallopeptidase domain 33 gene polymorphism and risk of childhood asthma: a meta-analysis
por: Sun, F.J., et al.
Publicado: (2017) -
Unravelling the role of ADAM 33 in asthma
por: Mahesh, P.A.
Publicado: (2013) -
Association of ADAM33 gene polymorphisms with allergic asthma
por: Karimi, Mohammad Reza Zand, et al.
Publicado: (2014)